Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR 0.2948
+0.0048 (1.66%)
Aug 29, 2025, 5:35 PM CET
Fidia Revenue
In the year 2024, Fidia had annual revenue of 17.53M EUR, down -38.98%. Fidia had revenue of 8.11M in the half year ending December 31, 2024, a decrease of -46.72%.
Revenue
17.53M
Revenue Growth
-38.98%
P/S Ratio
0.18
Revenue / Employee
110.28K
Employees
159
Market Cap
3.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.53M | -11.20M | -38.98% |
| Dec 31, 2023 | 28.74M | 4.07M | 16.52% |
| Dec 31, 2022 | 24.66M | 485.00K | 2.01% |
| Dec 31, 2021 | 24.18M | 2.52M | 11.65% |
| Dec 31, 2020 | 21.65M | -24.55M | -53.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Leonardo S.p.a. | 18.70B |
| Poste Italiane | 13.75B |
| Prysmian | 18.98B |
| Fincantieri | 8.84B |
| Iveco Group | 14.81B |
| Interpump Group | 2.06B |
| Maire | 6.65B |
| Webuild | 12.15B |
Fidia News
- 1 day ago - Legal group sues FDA over puberty blocker records citing Biden-era cover-up - Fox News
- 1 day ago - Press Release: Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia - Benzinga
- 1 day ago - FDA Approves Biogen, Eisai's Highly Anticipated Alzheimer's Treatment - Investor's Business Daily
- 1 day ago - The new head of the CDC has no training in medicine and once helped Peter Thiel develop man-made islands floating outside U.S. territory - Fortune
- 1 day ago - Why I'm Avoiding Nuvation Bio Despite Its Recent FDA Approval - Seeking Alpha
- 1 day ago - New FDA coronavirus vaccine rules bring U.S. closer to other countries - The Washington Post
- 1 day ago - Sagimet Gains Momentum As FDA Eases Path For MASH Drug Development - Seeking Alpha
- 1 day ago - FDA recommends increased monitoring of Alzheimer's patients on Leqembi - Seeking Alpha